Literature DB >> 21515873

Impact of a care pathway in acute pancreatitis.

Iain J D McCallum1, Gareth J Hicks, Stephen Attwood, Keith Seymour.   

Abstract

BACKGROUND: Previous studies have shown that accurate process of care predicts quality of care. Few examples currently exist for process of care for the acute surgical patient. A recent region wide audit had identified good outcomes for patients with acute pancreatitis at our institution but aspects of care that could be improved.
METHODS: For this re-audit, a simple written care pathway for the management of those presenting with acute pancreatitis was introduced in our institution from February to July 2009. The audit standards were set against the British Society of Gastroenterology (BSG) guidelines for management of acute pancreatitis and were compared with the previous region wide audit.
RESULTS: Marked improvements were noted in the rates of abdominal imaging achieved within 24 h of diagnosis (35.2% vs 47.7%), severity stratification within 48 h of diagnosis (28.7% vs 75%), critical care admission for those classified as severe (39.3% vs 63.6%) and definitive treatment during index admission (22.2% vs 38.5%). Survival rates were 100% for this audit cycle and 95% for all patients within the region wide audit. Despite these improvements, care still does not reach the standards set out by BSG.
CONCLUSION: Predefined processes of care may help to recognise those developing or likely to develop severe pancreatitis, ensure accurate documentation of severity, expedite critical care review and/or admission, and help to encourage the timely management of those with a treatable underlying cause of their pancreatitis.

Entities:  

Mesh:

Year:  2011        PMID: 21515873     DOI: 10.1136/pgmj.2010.002113rep

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  1 in total

Review 1.  Efficacy of Graded Emergency Nursing on Acute Pancreatitis Patients: A Meta-Analysis.

Authors:  Wenna Li; Qiuhong Cao
Journal:  Iran J Public Health       Date:  2021-06       Impact factor: 1.429

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.